4//SEC Filing
WILLIAMS FRANK J 4
Accession 0001628908-23-000053
CIK 0001628908other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 4:43 PM ET
Size
12.0 KB
Accession
0001628908-23-000053
Insider Transaction Report
Form 4
WILLIAMS FRANK J
DirectorChief Executive Officer
Transactions
- Sale
Class A Common Stock
2023-04-03$31.80/sh−104,126$3,311,207→ 825,686 total - Exercise/Conversion
Class A Common Option (right to buy)
2023-04-03−110,000→ 129,060 totalExercise: $6.87Exp: 2025-02-01→ Class A Common Stock (110,000 underlying) - Exercise/Conversion
Class A Common Stock
2023-04-03$6.87/sh+110,000$755,700→ 929,812 total - Sale
Class A Common Stock
2023-04-03$32.37/sh−5,874$190,141→ 819,812 total
Holdings
- 66,064(indirect: See footnote)
Class A Common Stock
Footnotes (6)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2022.
- [F2]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.138 to $32.135, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.14 to $32.57, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]Shares held of record by the Frank Williams Irrevocable Trust. Mr. Williams serves as the Trustee of the Frank Williams Irrevocable Trust.
- [F6]The Class A Common Stock Options exercised vested on February 1, 2018 and February 1, 2019.
Documents
Issuer
Evolent Health, Inc.
CIK 0001628908
Entity typeother
Related Parties
1- filerCIK 0001204938
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 4:43 PM ET
- Size
- 12.0 KB